Abstract Elevated levels of factor VII (FVII) and fibrinogen (Fb) have been reported as risk factors for coronary heart disease in middle-aged and older adults. The purpose of this study was to determine whether increased levels of these and other hemostatic factors (FVIII, von Willebrand factor [vWF]) were associated with other coronary risk factors in young adults participating in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Hemostatic factors were measured in 1724 participants aged 23 to 35 years who were roughly balanced by sex and race (black/white). Fb was greater in women than men (black, 288 versus 253 mg/dL; white, 267 versus 240 mg/dL; overall P<.05 by Scheffe multiple-comparison test), and FVIII and vWF were higher in blacks than in whites (FVIII in men, 103% versus 88%, and in women, 104% versus 91%; vWF in men, 114% versus 98%, and in women, 117% versus 99%; P<.05). The latter factors were lower in those with blood group O, but within each blood group (except A therosclerosis begins in youth and progresses dur-/ \ ing life to cause major cardiovascular morbidity J . \ . and mortality.
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David Green, Karen J. Ruth, Aaron R. Folsom, Kiang Liu Abstract Elevated levels of factor VII (FVII) and fibrinogen (Fb) have been reported as risk factors for coronary heart disease in middle-aged and older adults. The purpose of this study was to determine whether increased levels of these and other hemostatic factors (FVIII, von Willebrand factor [vWF] ) were associated with other coronary risk factors in young adults participating in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Hemostatic factors were measured in 1724 participants aged 23 to 35 years who were roughly balanced by sex and race (black/white). Fb was greater in women than men (black, 288 versus 253 mg/dL; white, 267 versus 240 mg/dL; overall P<.05 by Scheffe multiple-comparison test), and FVIII and vWF were higher in blacks than in whites (FVIII in men, 103% versus 88%, and in women, 104% versus 91%; vWF in men, 114% versus 98%, and in women, 117% versus 99%; P<.05). The latter factors were lower in those with blood group O, but within each blood group (except A therosclerosis begins in youth and progresses dur-/ \ ing life to cause major cardiovascular morbidity J . \ . and mortality. 12 The tempo of this progression is influenced by hyperlipidemia, hypertension, smoking, 34 and possibly other factors, including circulating procoagulants. 5 -7 Fibrinogen (Fb) in particular has been examined in several studies of myocardial infarction, stroke, and peripheral vascular disease and has been found to be pathophysiologically related to cardiovascular events. 8 Factor VII (FVII) has been strongly implicated in coronary artery disease 5 -69 and von Willebrand factor (vWF) in atherogenesis. 10 In instances of vascular injury, vWF mediates platelet adhesion and aggregation; FVII binds to exposed tissue factor and activates FIX and FX; and FVIII is required for further activation of FX, leading to thrombin generation and the conversion of Fb to fibrin. 11 Fb is also required for platelet aggregation.
Because atherogenesis is a lifelong process, the Coronary Artery Risk Development in Young Adults (CARDIA) Study has been designed to examine the evolution of various risk factors in young persons. 12 In a subgroup of the CARDIA population, we assayed (1) hemostatic factors (FVII, FVIII, vWF, and Fb) to determine the distribution of these procoagulants in healthy young adults, (2) constitutional factors (eg, sex and race) associated with their plasma concentrations, and (3) potential correlates between these hemostatic factors and other cardiovascular risk factors. In addition, because FVIII and vWF levels are influenced by blood group, 13 erythrocyte typing was performed for most participants.
Methods

The CARDIA Study
CARDIA is a national, collaborative, longitudinal study of lifestyles and the evolution of risk factors for cardiovascular diseases in young adults. Four centers -Chicago, Minneapolis, Birmingham, and Oakland -recruited a cohort of 5115 participants aged 18 to 30 at baseline (1985 to 1986) that was roughly balanced by sex, race (black/white), age (18 to 24, 25 to 30), and education (high school or less, more than high school). Repeated examinations were held in 1987 to 1988, 1990 to 1991, and 1992 to 1993 . For this investigation of procoagulant risk factors, 1724 participants from the Chicago and Minneapolis centers who were aged 23 to 35 years at the 1990 to 1991 examination were studied; the sample comprised all enrollees who returned for this periodic examination.
Coagulation Assays
Blood was drawn between 8 AM and 12 noon from participants who had fasted overnight. A 21-gauge butterfly needle was inserted into a large antecubital vein, the tourniquet was removed, and samples were collected for lipid analyses and chemistries. Then 5 mL blood was placed into each of two Vacutainer tubes containing 3.8% sodium citrate, mixed by repeated inversion, and spun at 3000g for 20 minutes at 4°C in a refrigerated centrifuge. This centrifugation was performed within 10 minutes of blood collection, and within 1 hour the plasma was placed in a -70°C freezer.
To avoid cold activation of FVII, 14 plasma was never held at 4°C except during the brief centrifugation. After storage for a maximum of 4 months, the samples were thawed at 37°C, kept at room temperature until tested, and analyzed. Samples collected in Minneapolis were packed in dry ice and sent to Chicago by overnight express. The blood collection and processing system was virtually identical to that of the Atherosclerosis Risk in Communities (ARIC) study, 15 in which this method of sample preparation and overnight storage on dry ice did not alter the concentrations of Fb, FVII, FVIII, or vWF.
Fb was assessed by the method of Gauss 16 with reagents from Dade Division, Baxter Healthcare Corp. The assay was calibrated with standard normal plasma (SNP reagent, Dade), and the results were calculated with the data management system of the MLA-Electra 800 clot timer.
FVII and FVIII coagulant activities were assayed by a one-stage system with reagents from Pacific Hemostasis and George King Biomedical, Inc. The standard curve was prepared by using universal reference plasma from Curtin Matheson Scientific and the results calculated as a percentage of standard with the data management system of the MLAElectra 800.
von Willebrand antigen was measured by an enzyme-linked immunosorbent assay 17 obtained from American Bioproducts Co. In brief, a plastic support coated with specific rabbit anti-human vWF antibodies bound vWF in the test plasma. Rabbit anti-vWF antibody coupled with peroxidase bound the remaining free antigenic determinants of vWF, and bound peroxidase was revealed by its activity on o-phenylenediamine in the presence of hydrogen peroxide. A standard curve was prepared with universal reference plasma, and the results were reported as a percentage of the standard.
The technical errors of the assays* were determined by internal and external testing. Internal quality control was performed by obtaining blood from five volunteers, splitting each sample into two parts, dividing each aliquot into four parts, and storing all sample splits at -20°C. Each week for 4 weeks, samples were retrieved and a complete set of assays was performed by technicians who were blinded to the identity of the samples. The technical error as a percent of the mean for Fb was 5.6±2.4%, for FVII 5.0±2.2%, for FVIII 6.0±2.3%, and for vWF antigen 7.6±1.5%.
In addition, external quality control was assessed by using split samples derived from 8% of the study participants (123 pairs). Duplicate samples were given bogus identification numbers, stored for varying times, and assayed as much as 4 months apart. The technical error for Fb was within 10% of the mean; for FVII and FVIII it was 13% to 14% of the mean; and for von Willebrand factor it was 17% of the mean. These higher technical errors reflect the greater complexity of this testing procedure and are probably more reflective of actual laboratory accuracy in assaying study samples.
Other Measurements
Sex, race, years of education, and number of cigarettes smoked per day were self-reported data obtained by interview or self-administered questionnaire. Height (to the nearest 0.5 cm) and weight (to the nearest 0.2 lb) were measured in light clothing without shoes. Body mass index was computed as weight (in kilograms) divided by height squared (in meters squared). Three measurements of resting systolic and diastolic fifth-phase blood pressures were taken by trained technicians using a random-zero sphygmomanom-
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eter. The average of the second and third measurements was used in the analyses.
Plasma total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides were determined by the University of Washington Northwest Lipid Research Clinic Laboratory. Total cholesterol and total triglyceride levels were determined using enzymatic procedures 18 on the ABA 200 bichromatic instrument. HDL-C was measured by enzymatic methods after dextran sulfate-magnesium precipitation.
19 LDL-C was estimated by the Friedewald equation, 20 whereby LDL-C=Total Cholesterol-HDL-C-(Triglycerides/5).
Blood group analysis was performed on unfrozen blood with reagents from Ortho Diagnostic Systems, Inc. Because of delays in funding, samples from early participants were frozen and blood typing was not performed.
Statistical Methods
Clotting factor percentile values (5th, 10th, 25th, 50th, 75th, 90th, and 95th) were determined for each sex-race group. Average clotting factor levels were compared among blood types within each race-sex group by one-way ANOVA and Scheffe multiple-comparison test. Pearson correlation coefficients were calculated between clotting factors and coronary heart disease risk factors.
Results
Clotting Factor Distributions by Sex and Race
The Figure shows the distribution of FVII, FVIII, vWF, and Fb by race and sex. Table 1 provides medians, means, and standard deviations of these distributions. No race/sex differences were observed in the distribution of FVII. However, FVIII and vWF tended to be higher in blacks than whites (overall P<.05, Scheffe multiple-comparison test) and Fb within gender was also higher in blacks than whites. Fb was higher in women than men (overall P<.05, Scheffe multiplecomparison test).
Influence of Blood Group
Blood group data were available for 70% of the participants. Table 2 shows the number of participants and the mean values for Fb, FVII, FVIII, and vWF by race, sex, and blood group. FVIII and vWF were lower in those with blood type O than the other blood types (overall P<.05, Scheffe multiple-comparison test). However, blacks with B, AB, and O blood had significantly higher levels of these factors than whites with these same blood groups (overall P<.05, Scheffe multiple-comparison test).
Correlation of Hemostatic Variables With Coronary Risk Factors
Pearson correlations of hemostatic factors with coronary risk factors are shown in Tables 3 through 5 . FVII correlated positively with body mass index, particularly in women and white men, with systolic and diastolic blood pressures, and with total cholesterol and triglycerides in all subjects. Strong positive correlations were also observed with LDL-C in all but black women. Table 4 shows correlations between FVIII/vWF and coronary risk factors in each race/sex group. While strong positive correlations were observed in white women between these factors and body mass index, total cholesterol, LDL-C, and triglycerides, weaker or no correlations were found in black women. Similarly, levels of FYIII correlated positively with blood pressure and triglycerides in white men but not in black men, and neither FVIII nor vWF correlated with cholesterol for either white or black men. No significant correlations were observed with smoking status in any group. Although smokers tended to have higher levels of FVIII/ vWF, differences were significant only for FVIII for white men (data not shown). Table 5 shows Pearson correlations for Fb with various coronary risk factors. Strong positive correlations were observed with body mass index, total cholesterol, and LDL-C in all groups. In all but black men, triglycerides were positively correlated and HDL-C negatively correlated with Fb. In addition, in men positive correlations were noted with blood pressure and in white men, with cigarette smoking. 
Discussion
FVII, FVIII, vWF, and Fb were measured in black women, black men, white women, and white men aged 23 to 35 years. Although FVII levels did not differ between race/sex groups, FVIII and vWF were higher in blacks than whites; Fb was higher in women than men, -.091
.08* See the footnote to Table 3 for abbreviations. *.05<P<.1; tP<-05; *P<0.01; §P<.001.
and within gender, higher in blacks than whites. Gill et al 13 have shown that vWF is highest in those with blood group AB and lowest in those with blood group O. It is also known that blood group B is more predominant in blacks. 21 Within each blood group except A, blacks were found to have higher levels of FVIII and vWF. These differences are presumably genetic, but very little is presently known about the regulation of plasma FVIII and vWF. On the other hand, evidence for genetic determinants of Fb 22 and FVII 23 levels has been presented.
Both CARDIA and ARIC 2425 are population-based studies, but the age of the participants at entry is different (CARDIA, 18 to 30 years; ARIC, 45 to 64 years). We compared the CARDIA results with those of ARIC and found that although clotting factor levels were higher in ARIC participants, the relationships were similar: ie, FVIII and Fb were higher in blacks, and Fb was higher in women than in men and in blacks than in whites. The ARIC investigators, 25 the MONICA study, 26 the Miinster Arteriosclerosis Study, 2728 and the Northwick Park Heart Study 29 examined the association of age with clotting factor concentrations; an increase with age was noted in all studies. Thus, differences in clotting factor levels between the ARIC study and the present analysis are probably due to the younger age of our participants.
Fb is an independent risk factor for myocardial infarction and stroke, 56 -30 carotid artery atherosclerosis, 31 cardiovascular events in stroke survivors, 32 and death in patients with intermittent claudication. 33 The Northwick Park Heart Study showed that FVII was a risk factor for ischemic heart disease 56 ; other studies have observed increased FVII activity in men at risk for cardiovascular disease, 934 although when other risk factors were considered (cholesterol, blood pressure, body mass index), this association was not sustained in the ARIC study of carotid atherosclerosis. 31 Both FVIII and vWF have been implicated in atherogenesis, 735 and a recent study showed that high concentrations of vWF were independently associated with an increased risk for recurrent myocardial infarction and mortality in survivors of myocardial infarction. 10 Therefore, it was important to measure the concentrations of these factors in young adults and to examine the relationship between these procoagulants and such factors as body mass index, lipids, blood pressure, and smoking.
Our investigation demonstrates that even in young adulthood, there are correlations between certain procoagulants and coronary risk factors. Specifically, we found that Fb correlated positively with body mass index, total cholesterol, and LDL-C in all subgroups and with blood pressure, triglycerides, and cigarette smoking in white men. FVII correlated positively with cholesterol and triglycerides in all subgroups and with LDL-C in whites. These correlations are similar to those in other studies 24 ' 2629 ' 36 that involved mostly older subjects and confirm the data of Hoffman et al 37 in a small study of first-year medical students (see Table 6 for a summary of these investigations).
The relationship between clotting factor levels and plasma lipids is enigmatic. Fb is an acute-phase reactant and is increased in many disorders in which lipid levels may also be elevated. 38 On the other hand, FVII bears a special relation to triglycerides: alterations in triglyceride levels affect plasma FVII activity. 39 It has been suggested that triglycerides may influence other membrane lipids 40 and could possibly enhance the binding of FVII to phospholipid. Such complexed FVII has increased clotting activity. 34 Our study suggests that certain clotting factors are subjected to the same genetic and environmental influences that raise lipid levels and increase blood pressure. The clotting factors examined in this study are potentially thrombogenic: Fb increases blood viscosity, FVII is required for initiation of the tissue factor pathway of coagulation, FVIII is necessary for the amplification of thrombin generation, and vWF enhances adherence of cellular elements to the vessel wall. 1141 It is possible that prolonged increases in these factors, beginning in young adulthood and extending over decades, in conjunction with other coronary risk factors may lead to vasoocclusive disease in middle age. In this regard, results of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) investigation of arteries from persons aged 15 through 34 years who died of external causes is of interest. 42 Compared with whites, blacks had a higher prevalence of atherosclerotic lesions involving 5% or more of the arterial surface of the right coronary artery as well as a greater mean percent area of artery involved with lesions. Our observations that blacks have higher levels of Fb and within blood group, higher levels of FVIII and vWF may be highly relevant to these observations.
In conclusion, our findings indicate that the distribution of Fb, FVIII, and vWF is different between genders and races. Although blood group influences levels of FVIII and vWF, even within a given blood group blacks have higher levels of these factors than whites. Furthermore, we have observed strong correlations between levels of specific clotting factors and established coronary risk factors, but these correlations may not hold true for all race/sex groups. How these differences will evolve in terms of the development of atherosclerotic vascular disease is the subject of our continuing investigation of coronary risk factors in young adults.
